Suzhou Suncadia Biopharmaceuticals
Cervical Cancer: Frontline SHR-1701 Plus BP102 and Chemo Shows Potent Activity
SG Tylor
The combination of the novel bifunctional fusion protein SHR-1701 with bevacizumab (BP102) and platinum-doublet chemotherapy has shown promising results in ...
